Virotag® Reagents

Rapid, Direct, Biologically Relevant Virus Quantitation

The Virus Counter® platform and Virotag® reagents were specially developed to quantify viruses rapidly and with high specificity utilizing the Virus Counter® instrument. The reagents offer a biologically-relevant readout with versatility to address unique quantification needs. Virus samples stained with Virotag® reagents are quantified after a 30-minute incubation.

Virotag® DY reagents are based on a dual stain approach that uses fluorogenic dyes to detect virus particles. The reagent can be used for the quantification of all enveloped viruses. The Virotag® reagent product line is based on an antibody-driven recognition of virus particles. Antibodies selected in the Virotag® reagents are labeled with fluorophores and are highly specific for indicated viruses.

Virotag® AB and Virotag® DY Reagents

Use the Virotag® AB (antibody-based) and Virotag® DY (dye-based) reagents to label your virus samples and analyze on the Virus Counter® instrument. Enables real-time tracking of virus titer in your process:

  • Optimize growth conditions
  • Maximize yields
  • Identify problems sooner

Target your specific virus with highly specific antibody-based reagents

Enveloped VirusVirotag® AB Reagent
Enveloped Virus (universal) 
Baculovirus (Virotag BCVB)
Influenza A (Virotag INVA)
Influenza B (Virotag INVB)
Lentivirus (Virotag VSVG*)

* for VSV-G pseudotyped Lentivirus

Virotag® AB Reagent (Antibody-based Detection)

Virotag® AB Reagent – The Ideal Quantification Solution

Antibody-Based Virus Detection for Direct and Reliable Particle Quantification

Virotag® AB reagents enable direct, biologically specific detection of virus particles using fluorescently labeled antibodies. By targeting defined viral epitopes, the system delivers reliable and real-time particle counts to support confident decision-making.

The antibody-based approach complements established analytical methods by providing an additional, direct measurement of total virus particles, enabling a more comprehensive understanding of viral samples.

  • Direct measurement of total virus particles
  • Biologically specific detection via antibody binding
  • Complements established analytical workflows
  • Enables faster access to decision-relevant data
  • Simple no-wash workflow for efficient sample processing

View Product

Virotag® Reagent Kits

Code     

AAV2-3

for Adeno-Associated Virus Serotypes 2, 3

BCVB

for Baculovirus

VSVG

for pseudo typed viruses such as Lentivirus or BacMam

INVA

for Influenza A seasonal flu virus

INVB

for Influenza B seasonal flu virus


Request a Quote

New - Virotag® DY Reagent (Universal Detection System)

Universal Detection

Virotag® DY Reagent

The Virotag® DY detection system is a ready-to-use, simple, and universal approach for virus quantification. This reagent is compatible with all enveloped viruses, with single or double-stranded DNA or RNA genome. This universal reagent is based on a dual strain approach that identifies intact virus particles by simultaneous detection of protein and nucleic acid signals. The use of fluorogenic dyes eliminates the need to wash.

  • Universal detection method for enveloped viruses
  • Detect and identify virus particles with a dual signal approach
  • Ready-to-use reagent with a simple no-wash protocol

Request a Quote

Related Assets

Application Note

Rapid, Real Time Quantification of Lentivirus Particles Using Antibody-Based Detection on the Virus Counter® 3100 Platform

PDF | 113.4 KB
Brochure

Meet the Virus Counter® Platform - Rapid, Direct, Biologically Relevant Virus Quantitation

PDF | 1.3 MB
Poster

Rapid Total Particle Quantification for Viral Families With High Potential for Pathogenic Emergence

PDF | 949.7 KB
Poster

Rapid, Real Time Quantification of Adeno-Associated Virus Particles Using Antibody-Based Detection on the Virus Counter® 3100

PDF | 1.4 MB

Q&A: Quantifying Viruses? Here’s What Matters Most

PDF | 174.8 KB

Consult Our Experts

Consult Our Experts

Related Content

Virus Quantification

Novel approach enabling direct, biologically-specific quantification of viruses in minutes rather than the days or weeks.

Vaccine Manufacturing, Process Development and Production

Regenerative Medicine

icon-shopping-cart
Ready to Buy?